EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 19 April 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 1,051 - 1,100 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
laccase SP 807	420-150-4	80498-15-3	Resp. Sens. 1
glucosidase, β-	232-589-7	9001-22-3	Resp. Sens. 1
cellulases with the exception of those specified elsewhere in this Annex	-	-	Resp. Sens. 1
cellulase	232-734-4	9012-54-8	Resp. Sens. 1
cellobiohydrolase, exo-	253-465-9	37329-65-0	Resp. Sens. 1
C,C'-azodi(formamide)	204-650-8	123-77-3	Resp. Sens. 1
amylases with the exception of those specified elsewhere in this Annex show/hide Amylase, fungal EC / List no: 232-742-8 \| CAS no: 9013-01-8 Bacteria, complex with amylase and proteinase EC / List no: - \| CAS no: 68920-42-3 Amylase, α-, Aspergillus oryzae EC / List no: 232-588-1 \| CAS no: 9001-19-8 Amylase, iso- EC / List no: 232-956-1 \| CAS no: 9067-73-6 Amylase, β- EC / List no: 232-566-1 \| CAS no: 9000-91-3 Amylase EC / List no: 232-567-7 \| CAS no: 9000-92-4 Amylase, bacterial EC / List no: 232-560-9 \| CAS no: 9000-85-5 Amylase, mixture with proteinase EC / List no: 685-079-5 \| CAS no: 9001-11-0 Amylase, gluco-, Rhizopus oryzae EC / List no: - \| CAS no: 152923-55-2 Amylase, mixed with proteinase, Bacillus cereus-fermented EC / List no: - \| CAS no: 68909-35-3 Amylase, mixed with proteinase, Bacillus thuringiensis-fermented EC / List no: - \| CAS no: 68909-36-4 Amylase, α- EC / List no: 232-565-6 \| CAS no: 9000-90-2 Amylase, alpha-, Bacillus amyloliquefaciens EC / List no: - \| CAS no: 152923-48-3 Amylase, gluco- EC / List no: 232-877-2 \| CAS no: 9032-08-0	-	-	Resp. Sens. 1
amylase, α-	232-565-6	9000-90-2	Resp. Sens. 1
(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate G-EXOMETHYLENE SULFOXIDE ESTER	412-800-0	76109-32-5	Resp. Sens. 1
(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate P-NITROBENZYLESTER PGSO	412-670-5	54275-93-3	Resp. Sens. 1
trans-4-phenyl-L-proline SQ 27,616	416-020-1	96314-26-0	Repr. 2; Skin Sens. 1
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated) SP 7053	415-930-6	-	Repr. 2; Skin Sens. 1
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919	416-860-9	777891-21-1	Repr. 2; Skin Sens. 1
Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Azadirachta indica, Meliaceae.	283-644-7	84696-25-3	Repr. 2; Skin Sens. 1
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol	428-970-4	13595-25-0	Repr. 2; Skin Sens. 1
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol	427-050-1	170016-25-8	Repr. 2; Skin Irrit. 2; Skin Sens. 1
benzyl 2,4-dibromobutanoate B2,4DBB	420-710-8	23085-60-1	Repr. 2; Skin Irrit. 2; Skin Sens. 1
silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions)	603-404-0	130328-20-0	Repr. 2; Skin Irrit. 2; Eye Dam. 1
4-tert-butylphenol	202-679-0	98-54-4	Repr. 2; Skin Irrit. 2; Eye Dam. 1
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate	606-523-6	203313-25-1	Repr. 2; STOT SE 3; Eye Irrit. 2; Skin Sens. 1A
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione	619-394-6	99105-77-8	Repr. 2; STOT RE 2; Skin Sens. 1A
tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione	608-879-8	335104-84-2	Repr. 2; STOT RE 2; Skin Sens. 1
(S)-2,3-dihydro-1H-indole-2-carboxylic acid [S]-2-INDOLINE CARBOXYLIC ACID	410-860-2	79815-20-6	Repr. 2; STOT RE 2; Skin Sens. 1
dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin- 4-ium acetate	250-778-2	31717-87-0	Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A
dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine	216-474-9	1593-77-7	Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
2-(4-tert-butylphenyl)ethanol TBPE	410-020-5	5406-86-0	Repr. 2; STOT RE 2; Eye Dam. 1
triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol	-	138182-18-0	Repr. 2; STOT RE 2
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate	432-270-4	221354-37-6	Repr. 2; STOT RE 2
oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one	254-637-6	39807-15-3	Repr. 2; STOT RE 2
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione	600-533-4	104206-82-8	Repr. 2; STOT RE 2
amitrole (ISO);1,2,4-triazol-3-ylamine	200-521-5	61-82-5	Repr. 2; STOT RE 2
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Skin Sens. 1
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; Lact.; STOT RE 2
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; Lact.; STOT RE 2
hexabromocyclododecane show/hide 1,2,5,6,9,10-hexabromocyclodecane EC / List no: 221-695-9 \| CAS no: 3194-55-6 beta-hexabromocyclododecane EC / List no: 603-802-4 \| CAS no: 134237-51-7 gamma-hexabromocyclododecane EC / List no: 603-804-5 \| CAS no: 134237-52-8 Hexabromocyclododecane EC / List no: 247-148-4 \| CAS no: 25637-99-4 alpha-hexabromocyclododecane EC / List no: 603-801-9 \| CAS no: 134237-50-6	247-148-4	25637-99-4	Repr. 2; Lact.
fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol	262-095-7	60168-88-9	Repr. 2; Lact.
1,2,5,6,9,10-hexabromocyclododecane	221-695-9	3194-55-6	Repr. 2; Lact.
valinamide D,L-VALINEAMIDE	402-840-7	20108-78-5	Repr. 2; Eye Irrit. 2; Skin Sens. 1
piperazine phosphate	217-775-8	1951-97-9	Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
piperazine hydrochloride	228-042-7	6094-40-2	Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
piperazine dihydrochloride	205-551-2	142-64-3	Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide QUESTAMIDE H	422-560-9	149591-38-8	Repr. 2; Eye Irrit. 2
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate SCARLET PE 3948	424-260-3	784157-49-9	Repr. 2; Eye Dam. 1
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram	811-438-4	1255734-28-1	Repr. 2; Acute Tox. 4; Skin Sens. 1B
methyl salicylate	204-317-7	119-36-8	Repr. 2; Acute Tox. 4; Skin Sens. 1B
phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile	238-887-3	14816-18-3	Repr. 2; Acute Tox. 4; Skin Sens. 1
bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate	260-300-4	56634-95-8	Repr. 2; Acute Tox. 4; Skin Sens. 1

Showing 1,051 - 1,100 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 19 April 2024. Database contains 4691 unique substances/entries.

Footer Nav Items